Key facts
- This page summarizes Joseph Y. Chang's Form 4 filing for NU SKIN ENTERPRISES, INC. (NUS).
- 9 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 03 Mar 2023, 17:32.
Joseph Y. Chang - 01 Mar 2023 Form 4 Insider Report for NU SKIN ENTERPRISES, INC. (NUS)
- Reporting relationship
- Chief Scientific Officer
- Issuer ticker
- NUS
- Reported as of
- 01 Mar 2023
- Net transaction value
- -$929,730
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2023, 17:32:02 UTC
- Prior SEC filing
- 16 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gregory Belliston as Attorney-in-Fact for Joseph Y. Chang
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joseph Y. Chang filed Form 4 for NU SKIN ENTERPRISES, INC. (NUS) on 03 Mar 2023.
Change
- Previous filing in this sequence was filed on 16 Feb 2023.
- Current net transaction value: -$929,730.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NUS
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $2,097,696
- Shares
- +68,485
- Change %
- +323%
- Price
- $30.63
- Shares after
- 89,719
- Date
- 01 Mar 2023
- Ownership
- Direct
NUS
transaction
Class A Common Stock
Sale
- Transaction value
- $2,769,533
- Shares
- -68,485
- Change %
- -76%
- Price
- $40.44
- Shares after
- 21,234
- Date
- 01 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
NUS
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $18,378
- Shares
- +600
- Change %
- +2.8%
- Price
- $30.63
- Shares after
- 21,834
- Date
- 02 Mar 2023
- Ownership
- Direct
NUS
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $742,980
- Shares
- +24,400
- Change %
- +112%
- Price
- $30.45
- Shares after
- 46,234
- Date
- 02 Mar 2023
- Ownership
- Direct
NUS
transaction
Class A Common Stock
Sale
- Transaction value
- $1,019,250
- Shares
- -25,000
- Change %
- -54%
- Price
- $40.77
- Shares after
- 21,234
- Date
- 02 Mar 2023
- Ownership
- Direct
- Footnotes
- F2
NUS
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 78,068
- Date
- 01 Mar 2023
- Ownership
- Held in irrevocable family trust
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NUS
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -42,485
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 01 Mar 2023
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 42,485
- Exercise price
- $30.63
- Footnotes
- F4
NUS
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -26,000
- Change %
- -98%
- Price
- $0.000000
- Shares after
- 600
- Date
- 01 Mar 2023
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 26,000
- Exercise price
- $30.63
- Footnotes
- F4
NUS
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -600
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 02 Mar 2023
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 600
- Exercise price
- $30.63
- Footnotes
- F4
NUS
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -24,400
- Change %
- -29%
- Price
- $0.000000
- Shares after
- 59,410
- Date
- 02 Mar 2023
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 24,400
- Exercise price
- $30.45
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.89 to $40.80, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.31 to $41.21, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
Footnote F3
This report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Footnote F4
Currently exercisable in full.